Transforming growth factor β1-induced cellular heterogeneity in the periosteum of rat parietal bones
✍ Scribed by Y. Taniguchi; T. Tanaka; K. Gotoh; R. Satoh; M. Inazu
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 613 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1432-0827
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A number of cytokines and growth factors may affect astrocyte proliferation and functions. Transforming growth factor-pl (TGF-P1) is a pleiotropic cytokine which exerts multiple effects on growth and differentiation of different cell types. TGF-P1 is present in low amounts in the normal brain. TGF-P
To study the mechanism of action of thyroid hormones on bone, we examined the effects of immunosuppressive and nonimmunosuppressive cyclosporins, as well as of transforming growth factor beta 1 (TGF beta 1), 17 beta-estradiol (E2), and dihydroxytestosterone (DHT) on thyroxine (T4)- and triiodothyron
High levels of the cell growth inhibitor transforming growth factor-beta1 (TGF-beta1) are often found in a variety of human cancers. However, the physiological significance of this overexpression depends on the availability of the biologically active form of TGF-beta1 within the extracellular matrix
to a selective reduction of the liver load with preneoplas-Previous studies have shown 5-to 10-fold higher rates tic cells. (HEPATOLOGY 1996;23:840-847.) of apoptosis in prestages of liver cancer (putative preneoplastic cell foci [PPF]) than in unaltered liver; fasting or withdrawal of tumor promote